Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2012 - 2026)

Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -14.04%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -63.16%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -58.34%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 97.17%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -87.09%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -14.91%
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn -86.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 -87.09%
Dec 31, 2025 -64.24%
Sep 30, 2025 -92.49%
Jun 30, 2025 -40.06%
Mar 31, 2025 -84.41%
Dec 31, 2024 -80.27%
Sep 30, 2024 -87.64%
Jun 30, 2024 -87.61%
Mar 31, 2024 338.05%
Dec 31, 2023 528.42%
Sep 30, 2023 -43.24%
Jun 30, 2023 -87.61%
Mar 31, 2023 -982.36%
Dec 31, 2022 -993.61%
Sep 30, 2022 985.17%
Jun 30, 2022 145.47%
Mar 31, 2022 -84.25%
Dec 31, 2021 -162.08%
Sep 30, 2021 2,019.23%
Jun 30, 2021 1,596.55%